GOLD SPONSOR

PRTM Management Consultants, LLC draws upon deep biopharmaceutical industry experience to serve Government and Government-focused clients. PRTM uses best-in-class industry models paired with government-proven frameworks to bring new countermeasures from early technology development to commercial-scale production. PRTM's teams deliver objective, apolitical strategies to your toughest biodefense problems. We help you understand best-in-class practices from both the commercial and government sectors. During all of our client engagements, PRTM works to deliver strategic value that lasts long after our consultants have departed.

SILVER SPONSORS

Baxter International Inc. is a global health-care company that, through its subsidiaries, assists health-care professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. Baxter Vaccines, a business unit of the Baxter BioScience division, is involved in researching, developing and manufacturing vaccines against infectious disease and for biosecurity. With approximately 51,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. www.baxtervaccines.com

The risk of acute cyanide poisoning related to smoke inhalation in structural fires or as a potential chemical terrorism weapon is under appreciated by most emergency response and emergency medicine professionals. This is due in large part to the fact that current treatment options have limitations. EMD Pharmaceuticals, the North American affiliate of Merck KGaA of Darmstadt, Germany, is developing a cyanide antidote in the United States. For more information on the use of cyanide antidotes in response to industrial accidents, smoke inhalation or potential terrorist activities, please contact us at www.emdpharmaceuticals.com.

Emergent BioSolutions is a biopharmaceutical company focused on the development and manufacture of ImmunobioticsT - products that direct the body's immune system to treat and prevent life-threatening diseases. Founded as the world's only supplier of FDA-licensed anthrax vaccine, the company has a leading presence in the biodefense industry and a diversified prophylactic and therapeutic product portfolio. This portfolio includes a marketed product BioThrax®, six clinical stage and five preclinical stage anti-infective vaccines and immunotherapeutics.

Since 1984, The Federal Market Group (FMG) has provided winning business solutions for those in government and those doing business with the government - supporting the pharmaceutical industry since 1995. Specialists in public contracts, we helped our clients win and manage more than $17 billion in government contracts over the past five years. Web link is www.gbs-llc.com

GenPhar, Inc. is a development-stage company with the mission to become a leading provider of biodefense and prophylactic/therapeutic vaccines for the world's most infectious viral diseases. GenPhar's advantage is its proven safe and effective ProVax and TheraVax vaccine platforms -- unique technology capable of producing multiple, multivalent vaccine products. Weblink: www.genphar.com

VaxGen, Inc. is a biopharmaceutical company engaged in the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious diseases, including anthrax, smallpox, and Meningitis B. The company has been awarded an $877.5 million U.S. government contract to provide 75 million doses of its recombinant anthrax vaccine for civilian biodefense. Based in Brisbane, Calif., VaxGen operates a wholly owned manufacturing facility in California and owns 22% of Celltrion, Inc., a South Korean operation established to provide contract manufacturing to the global pharmaceutical industry. For more information, please visit the company's web site at: http://www.vaxgen.com."

McKenna Long & Aldridge LLP is a leader in the growing field of public health care and Biodefense procurement. We provide legal advice, government affairs counseling and venture capital consulting to pharmaceutical and biotech companies interested in securing contracts from the National Institutes of Health, Centers for Disease Control, Office of Health and Safety, Department of Defense and the Department of Health and Human Services. With approximately 350 lawyers and public policy advisors, we provide business solutions in the areas of corporate law, government contracts, intellectual property and technology, complex litigation, public policy and regulatory affairs, international law, real estate and finance. To learn more, log on to www.mckennalong.com.

BRONZE SPONSOR: